A prospective investigation of predictive and modifiable risk factors for breast cancer in unaffected BRCA1 and BRCA2 gene carriers

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Guinan, Emer M ^a   Hussey, Juliette ^a   McGarrigle, Sarah A ^b   Healy, Laura A ^b   O'Sullivan, Jacintha N ^b   Bennett, Kathleen ^b   Connolly, Elizabeth M ^b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

Author keywords

Body composition; BRCA1; BRCA2; Breast cancer; Dietary intake; Metabolic syndrome; Physical activity; Telomere length

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; TUMOR MARKER;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY COMPOSITION; BREAST CANCER; CANCER LOCALIZATION; CANCER RISK; DIETARY INTAKE; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; HUMAN CELL; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MOLECULAR PATHOLOGY; PATIENT ASSESSMENT; PATIENT MONITORING; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYSICAL ACTIVITY; PREDICTION; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; RISK REDUCTION; TELOMERE HOMEOSTASIS; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CLINICAL PROTOCOLS; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; MUTATION; PROGNOSIS; PROSPECTIVE STUDIES; QUANTITATIVE TRAIT, HERITABLE; RISK FACTORS;

EID: 84875205144     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-138     Document Type: Article

References (53)

1. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations) Bethesda, MD: National Cancer Institute, http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER web site, April 2012.
2. King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003, 302(5645):643-646. 10.1126/science.1088759, 14576434.
3. Nkondjock A, Ghadirian P. Epidemiology of breast cancer among BRCA mutation carriers: an overview. Cancer Lett 2004, 205(1):1-8. 10.1016/j.canlet.2003.10.005, 15040392.
4. Pruthi S, Gostout BS, Lindor NM. Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer. Mayo Clin Proc 2010, 85(12):1111-1120. 10.4065/mcp.2010.0414, 2996153, 21123638.
5. Milne RL, Osorio A, Cajal TR, Vega A, Llort G, de la Hoya M, Diez O, Alonso MC, Lazaro C, Blanco I. The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain. Clin Cancer Res 2008, 14(9):2861-2869. 10.1158/1078-0432.CCR-07-4436, 18451254.
6. Tryggvadottir L, Sigvaldason H, Olafsdottir GH, Jonasson JG, Jonsson T, Tulinius H, Eyfjord JE. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000. J Natl Cancer Inst 2006, 98(2):116-122. 10.1093/jnci/djj012, 16418514.
7. World Cancer Research Fund/American Institute for Cancer Research Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective 2007, Washington, DC: AICR, World Cancer Research Fund/American Institute for Cancer Research.
8. Harvie M, Hooper L, Howell AH. Central obesity and breast cancer risk: a systematic review. Obes Rev 2003, 4(3):157-173. 10.1046/j.1467-789X.2003.00108.x, 12916817.
9. Pichard C, Plu-Bureau G, Neves ECM, Gompel A. Insulin resistance, obesity and breast cancer risk. Maturitas 2008, 60(1):19-30. 10.1016/j.maturitas.2008.03.002, 18485631.
10. Lynch BM, Neilson HK, Friedenreich CM. Physical activity and breast cancer prevention. Recent Results Cancer Res 2011, 186:13-42.
11. Bjorge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manjer J, Stocks T, Selmer R, Nagel G, Almquist M. Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev 2010, 19(7):1737-1745. 10.1158/1055-9965.EPI-10-0230, 20615887.
12. Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, Schunemann HJ, Ram M, Freudenheim JL, Sieri S, Trevisan M. Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2002, 11(11):1361-1368.
13. Del Giudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D, Goodwin PJ. Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 1998, 47(2):111-120. 10.1023/A:1005831013718, 9497099.
14. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X, Anderson GL. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2009, 101(1):48-60. 2639294, 19116382.
15. Rose DP, Komninou D, Stephenson GD. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 2004, 5(3):153-165. 10.1111/j.1467-789X.2004.00142.x, 15245384.
16. Neilson HK, Friedenreich CM, Brockton NT, Millikan RC. Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research. Cancer Epidemiol Biomarkers Prev 2009, 18(1):11-27. 10.1158/1055-9965.EPI-08-0756, 19124476.
17. Ballard-Barbash R, Friedenreich CM, Courneya KS, Siddiqi SM, McTiernan A, Alfano CM. Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Natl Cancer Inst 2012, 104(11):815-840. 10.1093/jnci/djs207, 22570317.
18. Kotsopoulos J, Olopado OI, Ghadirian P, Lubinski J, Lynch HT, Isaacs C, Weber B, Kim-Sing C, Ainsworth P, Foulkes WD. Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 2005, 7(5):R833-843. 10.1186/bcr1293, 1242151, 16168130.
19. Manders P, Pijpe A, Hooning MJ, Kluijt I, Vasen HF, Hoogerbrugge N, van Asperen CJ, Meijers-Heijboer H, Ausems MG, van Os TA. Body weight and risk of breast cancer in BRCA1/2 mutation carriers. Breast Cancer Res Treat 2011, 126(1):193-202. 10.1007/s10549-010-1120-8, 20730487.
20. Nkondjock A, Robidoux A, Paredes Y, Narod SA, Ghadirian P. Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians. Breast Cancer Res Treat 2006, 98(3):285-294. 10.1007/s10549-006-9161-8, 16541324.
21. Pijpe A, Manders P, Brohet RM, Collee JE, Verhoef S, Vasen HR. Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers. Breast Cancer Res Treat 2010, 120:235-44. 10.1007/s10549-009-0476-0, 19680614.
22. Rashid-Kolvear F, Pintilie M, Done SJ. Telomere length on chromosome 17q shortens more than global telomere length in the development of breast cancer. Neoplasia 2007, 9(4):265-270. 10.1593/neo.07106, 1854852, 17460770.
23. Shen J, Terry MB, Gurvich I, Liao Y, Senie RT, Santella RM. Short telomere length and breast cancer risk: a study in sister sets. Cancer Res 2007, 67(11):5538-5544. 10.1158/0008-5472.CAN-06-3490, 17545637.
24. Xing J, Ajani JA, Chen M, Izzo J, Lin J, Chen Z, Gu J, Wu X. Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for esophageal cancer. Cancer Prev Res (Phila) 2009, 2(5):459-465.
25. Gramatges MM, Telli ML, Balise R, Ford JM. Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controls. Cancer Epidemiol Biomarkers Prev 2010, 19(2):605-613. 10.1158/1055-9965.EPI-09-0896, 20142254.
26. Martinez-Delgado B, Yanowsky K, Inglada-Perez L, Domingo S, Urioste M, Osorio A, Benitez J. Genetic anticipation is associated with telomere shortening in hereditary breast cancer. PLoS Genet 2011, 7(7):e1002182. 10.1371/journal.pgen.1002182, 3145621, 21829373.
27. Puterman E, Lin J, Blackburn E, O'Donovan A, Adler N, Epel E. The power of exercise: buffering the effect of chronic stress on telomere length. PLoS One 2010, 5(5):e10837. 10.1371/journal.pone.0010837, 2877102, 20520771.
28. Lin J, Puterman E, O'Donovan A, Krauss J, Lazaro A, Truong W, Cheon J, Epel E, Blackburn EH. Psychological stress and its relationship to telomere length maintenance. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research: 2011; Orlando, FL: AACR. Cancer Res 2011, 71(8 Suppl).
29. Milne RL, Osorio A, Ramon Y CT, Baiget M, Lasa A, Diaz-Rubio E, De la Hoya M, Caldes T, Teule A, Lazaro C. Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 2010, 119(1):221-232. 10.1007/s10549-009-0394-1, 19370414.
30. Kotsopoulos J, Lubinski J, Salmena L, Lynch HT, Kim-Sing C, Foulkes WD, Ghadirian P, Neuhausen SL, Demsky R, Tung N. Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 2012, 14(2):R42. 10.1186/bcr3138, 3446376, 22405187.
31. Ochoa EM, Gomez-Acebo I, Rodriguez-Cundin P, Navarro-Cordoba M, Llorca J, Dierssen-Sotos T. Relationship between family history of breast cancer and health-related behavior. Behav Med 2010, 36(4):123-129. 10.1080/08964289.2010.516783, 21186435.
32. Spector D, Deroo LA, Sandler DP. Lifestyle behaviors in black and white women with a family history of breast cancer. Prev Med 2011, 52(5):394-397. 10.1016/j.ypmed.2011.03.001, 3096469, 21396953.
33. World Health Organization Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation 2008, 8-11. Geneva: World Health Organization, World Health Organization.
34. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289(19):2560-2572. 10.1001/jama.289.19.2560, 12748199.
35. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419. 10.1007/BF00280883, 3899825.
36. Riboli E, Kaaks R. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997, 1:S6-14.
37. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002, 30(10):e47. 10.1093/nar/30.10.e47, 115301, 12000852.
38. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120(16):1640-1645. 10.1161/CIRCULATIONAHA.109.192644, 19805654.
39. Rowlands AV, Thomas PW, Eston RG, Topping R. Validation of the RT3 triaxial accelerometer for the assessment of physical activity. Med Sci Sports Exerc 2004, 36(3):518-524. 10.1249/01.MSS.0000117158.14542.E7, 15076796.
40. Powell SM, Jones DI, Rowlands AV. Technical variability of the RT3 accelerometer. Med Sci Sports Exerc 2003, 35(10):1773-1778. 10.1249/01.MSS.0000089341.68754.BA, 14523319.
41. Taylor HL, Jacobs DR, Schucker B. A questionnaire for the assessment of leisure time physical activities. J Chronic Dis 1978, 31(12):741-755. 10.1016/0021-9681(78)90058-9, 748370.
42. Ainsworth BE, Jacobs DR, Leon AS, Richardson MT, Montoye HJ. Assessment of the accuracy of physical activity questionnaire occupational data. J Occup Med 1993, 35(10):1017-1027.
43. Steele R, Mummery K. Occupational physical activity across occupational categories. J Sci Med Sport 2003, 6(4):398-407. 10.1016/S1440-2440(03)80266-9, 14723390.
44. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O'Brien WL, Bassett DR, Schmitz KH, Emplaincourt PO. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000, 32(9 Suppl):S498-504.
45. Richardson MT, Leon AS, Jacobs DR, Ainsworth BE, Serfass R. Comprehensive evaluation of the Minnesota Leisure Time Physical Activity Questionnaire. J Clin Epidemiol 1994, 47(3):271-281. 10.1016/0895-4356(94)90008-6, 8138837.
46. Jacobs DR, Ainsworth BE, Hartman TJ, Leon AS. A simultaneous evaluation of 10 commonly used physical activity questionnaires. Med Sci Sports Exerc 1993, 25(1):81-91. 10.1249/00005768-199301000-00012, 8423759.
47. Wilbur J, Holm K, Dan A. A quantitative survey to measure energy expenditure in midlife women. J Nurs Meas 1993, 1(1):29-40.
48. Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci 1985, 10(3):141-146.
49. Courneya KS, Mackey JR, Bell GJ, Jones LW, Field CJ, Fairey AS. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol 2003, 21(9):1660-1668. 10.1200/JCO.2003.04.093, 12721239.
50. Stevinson C, Faught W, Steed H, Tonkin K, Ladha AB, Vallance JK, Capstick V, Schepansky A, Courneya KS. Associations between physical activity and quality of life in ovarian cancer survivors. Gynecol Oncol 2007, 106(1):244-250. 10.1016/j.ygyno.2007.03.033, 17493671.
51. Schofield WN. Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr 1985, 39(Suppl 1):5-41.
52. Harrington, Janus, Perry, Ivan, Lutomski, Jennifer, Morgan, Karen, McGee, Hannah, Shelley, Emer, Watson, Dorothy, Barry, Margaret. SLAN 2007: Survey of Lifestyle, Attitudes and Nutrition in Ireland. Dietary Habits of the Irish Population (2008). Psychology Reports Paper 6. http://epubs.rcsi.ie/psycholrep/6.
53. Harrington J. Validation of a Food Frequency Questionnaire as a tool for assessing nutrient intake 1997, Galway: National University of Ireland.